This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Georges-Courbot, M. C.
Right arrow Articles by Deubel, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Georges-Courbot, M. C.
Right arrow Articles by Deubel, V.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, May 2006, p. 1768-1772, Vol. 50, No. 5
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.5.1768-1772.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Poly(I)-Poly(C12U) but Not Ribavirin Prevents Death in a Hamster Model of Nipah Virus Infection

M. C. Georges-Courbot,1* H. Contamin,1 C. Faure,1 P. Loth,1 S. Baize,1 P. Leyssen,2 J. Neyts,2 and V. Deubel1,{dagger}

Unité de Biologie des infections virales émergentes, Institut Pasteur, Laboratoire P4, Jean Mérieux Inserm, Institut Fédératif de Recherche 128-Biosciences Lyon Gerland, 21 Avenue Tony Garnier, 69365 Lyon, France,1 Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium2

Received 13 September 2005/ Returned for modification 8 December 2005/ Accepted 15 February 2006

Clinical nonrandomized trials demonstrate some efficacy for ribavirin in the treatment of patients with severe Nipah virus-induced encephalitis. We report here that EICAR, the 5-ethynyl analogue of ribavirin, and the OMP-decarboxylase inhibitors 6-aza-uridine and pyrazofurin have strong antiviral activity against Nipah virus replication in vitro. Ribavirin and 6-aza-uridine were tested further in hamsters infected with a lethal dose of Nipah virus. The activity of these small-molecule inhibitors was compared with that of the interferon inducer poly(I)-poly(C12U). Both ribavirin and 6-aza-uridine were able to delay but not prevent Nipah virus-induced mortality. Poly(I)-poly(C12U), at 3 mg/kg of body weight daily from the day of infection to 10 days postinfection, prevented mortality in 5 of 6 infected animals.


* Corresponding author. Mailing address: Unité de Biologie des infections virales émergentes, Institut Pasteur, Laboratoire P4, Jean Mérieux Inserm, Institut Fédératif de Recherche 128-Biosciences Lyon Gerland, 21 Avenue Tony Garnier, 69365 Lyon, France. Phone: 33 4 37 28 24 43. Fax: 33 4 37 28 24 41. E-mail: mgeorges{at}cervi-lyon.inserm.fr.

{dagger} Present address: Institut Pasteur of Shanghai, Chinese Academy of Sciences, 225 South Chongqin Road, 200025 Shanghai, People's Republic of China.


Antimicrobial Agents and Chemotherapy, May 2006, p. 1768-1772, Vol. 50, No. 5
0066-4804/06/$08.00+0     doi:10.1128/AAC.50.5.1768-1772.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Lo, M. K., Harcourt, B. H., Mungall, B. A., Tamin, A., Peeples, M. E., Bellini, W. J., Rota, P. A. (2009). Determination of the henipavirus phosphoprotein gene mRNA editing frequencies and detection of the C, V and W proteins of Nipah virus in virus-infected cells. J. Gen. Virol. 90: 398-404 [Abstract] [Full Text]  
  • Mungall, B. A., Middleton, D., Crameri, G., Bingham, J., Halpin, K., Russell, G., Green, D., McEachern, J., Pritchard, L. I., Eaton, B. T., Wang, L.-F., Bossart, K. N., Broder, C. C. (2006). Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine. J. Virol. 80: 12293-12302 [Abstract] [Full Text]